SEQUENT.NS

Sequent Scientific Limited [SEQUENT.NS] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

SEQUENT.NS Stock Summary

In the News

SEQUENT.NS Financial details

Company Rating
-
Market Cap
30.81B
Income
-1.29B
Revenue
13.75B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
1.3K
Optionable
No
Shortable
Yes
Earnings
21 May 2024
P/E
-23.22
Forward P/E
-
PEG
0.57
P/S
2.23
P/B
5.36
P/C
-
P/FCF
191.7
Quick Ratio
0.65
Current Ratio
1.28
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-5.18
EPS next Y
-
EPS next Q
-
EPS this Y
-392.22%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
6.84%
Revenue Q/Q
-4.8%
EPS Q/Q
-197.06%
-
-
-
-
SMA20
-1.64%
SMA50
28.6%
SMA100
16.05%
Inst Own
-
Inst Trans
-
ROA
-10%
ROE
-20%
ROC
-0.06%
Gross Margin
42%
Oper. Margin
-4%
Profit Margin
-10%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
69.8-155.5
52W High
+21.54%
52W Low
+173.01%
RSI
51.56
Rel Volume
0.2
Avg Volume
1.88M
Volume
383.61K
Perf Week
-2.89%
Perf Month
4.7%
Perf Quarter
1.05%
Perf Half Y
2.02%
-
-
-
-
Beta
0.507
-
-
Volatility
2.35%, 4.51%
Prev Close
1.34%
Price
188.38
Change
1.8%

Something similar

Top by Market Cap
ABEA.DE
ABEC.DE
AAPL
VFINX
BRK-B
Same Sector
FRLN
0NIQ.L
ACRX
PIII
2192.HK
Same Price Range
NLCINDIA.NS
HUDCO.NS
SJG.L
VRSN
2385.TW
Similar Market Cap
6188.TWO
5702.T
XGSD.L
2930.T
3150.T

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 1.88M
  • Market Capitalization 30.81B
  • Employee 1.3K
  • CEO Mr. Rajaram Narayanan
  • Headquarters Mumbai,IN
  • IPO Date 2016-03-10
  • Website https://www.sequent.in

Sequent Scientific Limited engages in the animal health business worldwide. The company provides animal health active pharmaceutical ingredients (APIs) and finished dosage formulations in the areas of feed supplements, antibiotics, anthelmintics, antibacterial, anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It offers analytical solutions that supports API, pharmaceutical, personal care, and nutraceutical organizations, as well as provides method validation, stability, and microbiology for APIs and finished products. The company was formerly known as PI Drugs and Pharmaceuticals Limited and changed its name to Sequent Scientific Limited in October 2009. Sequent Scientific Limited was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited operates as a subsidiary of CA Harbor Investments.